Skip to main content

Byung‐Hyun Lee

Korea University · 医学

研究室紹介

Professor Byung-Hyun Lee's research lab specializes in translational oncology and regenerative medicine, with a focus on tumor immunology and molecular mechanisms underlying hematologic malignancies such as multiple myeloma. The lab investigates immune checkpoint molecules like PD-L1 and PVR (CD155) to understand their prognostic and therapeutic implications in cancer. It also explores innovative regenerative strategies, including the use of conditioned media from placenta-derived cells to enhance induced pluripotent stem cell (iPSC) reprogramming through mTOR and cMYC signaling. Additionally, the lab contributes to clinical research on hypomethylating agents in myelodysplastic syndromes and diagnostic tools for immune thrombocytopenia.

multiple myelomaimmune checkpointsiPSC reprogramminghypomethylating agentsmyelodysplastic syndromes

Research Overview

Papers
68
Total Citations
299
Papers (5y)
33
Primary Field
医学

Research Output Trend

Figures are computed from collected data and may differ slightly.

Publications per year (5y)
33total
2021
2022
2023
2024
2025
Citations per year (5y)
102total
20212022202320242025

Selected Papers

15
1
Article|34 citations·2020
PD-L1 expression in bone marrow plasma cells as a biomarker to predict multiple myeloma prognosis: developing a nomogram-based prognostic model
Byung‐Hyun Lee, Yong Park, Ji Hye Kim, Ka‐Won Kang, Seung Jin Lee, Seok Jin Kim, Byung Soo Kim
SJR Q1Scientific ReportsOA

PD-L1 expression is associated with poor prognosis, although this relationship is unclear in bone marrow-derived haematologic malignancies, including multiple myeloma. We aimed to determine whether PD-L1 expression could predict the prognosis of newly diagnosed multiple myeloma (NDMM). We evaluated 126 NDMM patients (83, retrospectively; 43, prospectively) who underwent bone marrow examinations. Bone marrow aspirates were analysed for PD-L1 expression, categorized as low or high expression, usin

HematologyMedicine
2
Article|19 citations·2020
Comparison between 5-day decitabine and 7-day azacitidine for lower-risk myelodysplastic syndromes with poor prognostic features: a retrospective multicentre cohort study
Byung‐Hyun Lee, Ka‐Won Kang, Min Ji Jeon, Eun Sang Yu, Dae Sik Kim, Hojoon Choi, Se Ryeon Lee, Hwa Jung Sung, Byung Soo Kim, Chul Won Choi, Yong Park
SJR Q1Scientific ReportsOA

Numerous studies have analysed the clinical efficacies of hypomethylating agents (HMAs) in patients with myelodysplastic syndromes (MDS). However, reports that compare the two HMAs, decitabine and azacitidine, in patients with lower-risk (low and intermediate-1) MDS are limited. We compared 5-day decitabine and 7-day azacitidine regimens in terms of treatment responses, survival outcomes, and adverse events in patients with lower-risk MDS with poor prognostic features. The overall response rates

HematologyMedicine
3
Article|17 citations·2020
Immature platelet fraction based diagnostic predictive scoring model for immune thrombocytopenia
Min Ji Jeon, Eun Sang Yu, Ka‐Won Kang, Byung‐Hyun Lee, Yong Park, Se Ryeon Lee, Hwa Jung Sung, Soo Yong Yoon, Chul Won Choi, Byung Soo Kim, Dae Sik Kim
SJR Q2The Korean Journal of Internal MedicineOA

IPF could be a useful parameter to distinguish ITP from other causes of thrombocytopenia. We developed the predictive scoring model. This model could predict ITP with high probability.

HematologyMedicine
4
Article|17 citations·2014
Two Cases of Diagnosis and Removal of Endobronchial Hamartoma by Cryotherapy via Flexible Bronchoscopy
Jae Kyeom Sim, Jong Hyun Choi, Jee Youn Oh, Jae Young Cho, Eul Sun Moon, Hye Sook Min, Byung Hyun Lee, Min Seon Park, Gyu Young Hur, Sung Yong Lee, Jae Jeong Shim, Kyung Ho Kang
SJR Q2Tuberculosis & respiratory diseasesOA

Although endobronchial hamartoma is a rare benign tumor, most patients with endobronchial hamartoma have respiratory symptoms such as obstructive pneumonia, hemoptysis, cough, or dyspnea due to bronchial obstruction. It can cause irreversible post-obstructive pulmonary destruction, thus early diagnosis and treatment is very important. Recently, there have been cases of neodymium-doped yttrium aluminum garnet (Nd:YAG) laser and electrocautery procedures for bronchoscopic treatment of malignant or

Pulmonary and Respiratory MedicineMedicine
5
Article|16 citations·2022
PVR (CD155) Expression as a Potential Prognostic Marker in Multiple Myeloma
Byung‐Hyun Lee, Ji-Hea Kim, Ka‐Won Kang, Se-Ryeon Lee, Yong Park, Hwa-Jung Sung, Byung‐Soo Kim
SJR Q1BiomedicinesOA

Poliovirus receptor (PVR, CD155) is upregulated during tumor progression, and PVR expression is associated with poor prognosis in cancer patients; however, prognostic implications for PVR in multiple myeloma (MM) have not been investigated. PVR plays an immunomodulatory role by interacting with CD226, CD96, and TIGIT. TIGIT is a checkpoint inhibitory receptor that can limit adaptive and innate immunity, and it binds to PVR with the highest affinity. We used immunohistochemistry, ELISA, qPCR, and

HematologyMedicine
6
Article|15 citations·2019
CXCR2 Ligands and mTOR Activation Enhance Reprogramming of Human Somatic Cells to Pluripotent Stem Cells
Seung Jin Lee, Ka‐Won Kang, Ji-Hea Kim, Byung‐Hyun Lee, Ji-Hye Jung, Yong Park, Soon–Cheol Hong, Byung‐Soo Kim
SJR Q2Stem Cells and Development

Induced pluripotent stem cell (iPSC) technology has great promise in regenerative medicine and disease modeling. In this study, we show that human placenta-derived cell conditioned medium stimulates chemokine (C-X-C motif) receptor 2 (CXCR2) in human somatic cells ectopically expressing the pluripotency-associated transcription factors <i>Oct4</i>, <i>Sox2</i>, <i>Klf4</i>, and <i>cMyc</i> (OSKM), leading to mechanistic target of rapamycin (mTOR) activation. This causes an increase in endogenous

Molecular BiologyBiochemistry, Genetics and Molecular Biology
7
Article|14 citations·2019
Single‐dose etoposide is an effective and safe protocol for stem cell mobilization in patients with multiple myeloma
Yong Park, Dae Sik Kim, Min Ji Jeon, Byung‐Hyun Lee, Eun Sang Yu, Ka‐Won Kang, Se Ryeon Lee, Hwa Jung Sung, Myung‐Hyun Nam, Soo‐Young Yoon, Chul Won Choi, Eun‐Suk Kang
SJR Q2Journal of Clinical Apheresis

Abstract Background Single‐dose etoposide was used an outpatient‐based protocol for mobilization in patients with multiple myeloma (MM) for autologous stem cell transplantation (ASCT). Thus, we retrospectively analyzed the efficacy and safety of our one‐day protocol in comparison with that of previous methods. Methods We retrospectively analyzed 168 patients with MM who underwent peripheral blood stem cell collection for upfront ASCT between 2008 and 2018. The mobilization protocols included G‐C

HematologyMedicine
8
Article|10 citations·2021
Prognostic Value of Galectin-9 Relates to Programmed Death-Ligand 1 in Patients With Multiple Myeloma
Byung‐Hyun Lee, Yong Park, Ji-Hea Kim, Ka‐Won Kang, Seung Jin Lee, Seok Jin Kim, Byung Soo Kim
SJR Q2Frontiers in OncologyOA

Galectin-9 (Gal-9) expression can be negatively or positively associated with cancer patient prognosis, depending on the cancer type. However, the nature of this relationship remains unclear in multiple myeloma. Therefore, we evaluated the prognostic value of Gal-9 and its relationship with the expression of PD-L1 molecule, the most widely studied immune checkpoint inhibitor, in patients with newly diagnosed multiple myeloma. Gal-9 and PD-L1 levels in bone marrow aspirate samples were evaluated

ImmunologyImmunology and Microbiology
9
Article|8 citations·2022
Blood Transfusion, All-Cause Mortality and Hospitalization Period in COVID-19 Patients: Machine Learning Analysis of National Health Insurance Claims Data
Byung‐Hyun Lee, Kwang‐Sig Lee, Hae-In Kim, Jae Seung Jung, Hyeon Ju Shin, Jonghoon Park, Soon Cheol Hong, Ki Hoon Ahn
SJR Q2DiagnosticsOA

This study presents the most comprehensive machine-learning analysis for the predictors of blood transfusion, all-cause mortality, and hospitalization period in COVID-19 patients. Data came from Korea National Health Insurance claims data with 7943 COVID-19 patients diagnosed during November 2019−May 2020. The dependent variables were all-cause mortality and the hospitalization period, and their 28 independent variables were considered. Random forest variable importance (GINI) was introduced for

Infectious DiseasesMedicine
10
Preprint|5 citations·2022
PVR (CD155) Expression as a Potential Prognostic Marker in Multiple Myeloma
Byung‐Hyun Lee, Ji-Hea Kim, Ka‐Won Kang, Se Ryeon Lee, Yong Park, Hwa Jung Sung, Byung Soo Kim
Research SquareOA
HematologyMedicine
11
Article|3 citations·2016
Investigation of the Contact Resistance Between Amorphous Silicon-Zinc-Tin-Oxide Thin Film Transistors and Different Electrodes Using the Transmission Line Method
이병현, Sangmin Han, Sang Yeol Lee

A thin film transistor (TFT) has been fabricated using the amorphous 0.5 wt% Si doped zinc-tin-oxide (a-0.5 SZTO) with different electrodes made of either aluminium (Al) or titanium/aluminium(Ti/Al). Contact resistance and total channel resistance of a-0.5SZTO TFTs have been investigated and compared using the transmission line method (TLM). We measured the total resistance of 1.0×102 Ω/cm using Ti/Al electrodes. This result is due to Ti, which is a material known for its adhesion layer. We foun

12
Article|3 citations·2021
Clinical Efficacy of Ruxolitinib in Patients with Myelofibrosis: A Nationwide Population-Based Study in Korea
Byung‐Hyun Lee, Hyemi Moon, Jae-Eun Chae, Ka‐Won Kang, Byung‐Soo Kim, Juneyoung Lee, Yong Park
SJR Q1Journal of Clinical MedicineOA

Previous studies have reported the survival benefit after ruxolitinib treatment in patients with myelofibrosis (MF). However, population-based data of its efficacy are limited. We analyzed the effects of ruxolitinib in MF patients with data from the Korean National Health Insurance Database. In total, 1199 patients diagnosed with MF from January 2011 to December 2017 were identified, of which 731 were included in this study. Patients who received ruxolitinib (n = 224) were matched with those who

GeneticsMedicine
13
Article|2 citations·2021
Prediction Model for Cereblon Expression in Bone Marrow Plasma Cells Based on Blood Markers in Multiple Myeloma Patients
Byung‐Hyun Lee, Ka‐Won Kang, Min Ji Jeon, Eun Sang Yu, Dae Sik Kim, Se Ryeon Lee, Hwa Jung Sung, Yong Park, Chul Won Choi, Byung Soo Kim
SJR Q2Frontiers in OncologyOA

BACKGROUND: Cereblon (CRBN) is a direct target of immunomodulatory drugs (IMiDs) and is known to be sensitive and responsive to IMiD therapy. We evaluated CRBN expression in bone marrow plasma cells and analyzed whether CRBN expression was associated with multiple myeloma prognosis. Lastly, we developed a nomogram model for predicting high CRBN expression based on clinically significant blood markers. METHODS: We evaluated 143 multiple myeloma patients (internal dataset) who underwent bone marro

HematologyMedicine
14
Article|2 citations·2023
Prognostic outcomes of cytomegalovirus reactivation after autologous stem cell transplantation
Byung‐Hyun Lee, Min Ji Jeon, Eun Sang Yu, Ka‐Won Kang, Dae Sik Kim, Se Ryeon Lee, Yong Park, Hwa Jung Sung, Chul Won Choi, Byung Soo Kim
SJR Q2International Journal of Medical SciencesOA

<b>Background:</b> Cytomegalovirus (CMV) reactivation is a common complication in patients undergoing allogeneic stem cell transplantation. However, the incidence of CMV reactivation is low after autologous stem cell transplantation (auto-SCT), and the prognostic value of CMV reactivation remains controversial. Moreover, reports on late CMV reactivation after auto-SCT are limited. We aimed to analyze the association between CMV reactivation and survival outcomes and develop a predictive model fo

EpidemiologyMedicine
15
Article|1 citations·2018
Immature Platelet Fraction Based Diagnostic Predictive Model for Immune Thrombocytopenic Purpura
Min Ji Jeon, Hojoon Choi, Eun Sang Yu, Ka‐Won Kang, Byung‐Hyun Lee, Dae Sik Kim, Yong Park, Se Ryeon Lee, Hwa Jung Sung, Chul Won Choi, Byung Soo Kim
SJR Q1Blood

Abstract Introduction Immune thrombocytopenic purpura (ITP) is known as an acquired, immune-mediated disease characterized by isolated thrombocytopenia. Many studies have asserted that a diagnosis of ITP does not require a routine bone marrow examination. However, bone marrow examination is necessary in many cases because the diagnosis of ITP requires exclusion of other diseases including bone marrow disease. As both physicians and patients are reluctant to perform an invasive bone marrow examin

HematologyMedicine

Research Areas

HematologyMolecular BiologyImmunologyGeneticsPharmacologyPulmonary and Respiratory Medicine

Byung‐Hyun Leeの研究をNubintでさらに深く

この研究室の論文をアプリで開き、AIと共に読み、要約し、引用しましょう。